SCHEMBL19212236

SCHEMBL19212236

CN(Cc1ccccc1)c1cc(F)cc(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.49
NR1H3 Q13133 1/20 0.49
TSHR P16473 3/20 0.48
ALDH1A1 P00352 2/20 0.48
AOC3 Q16853 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
NTRK1 P04629 1/20 0.43
NTRK3 Q16288 1/20 0.43
NTRK2 Q16620 1/20 0.43
MAPT P10636 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
IP6K1 Q92551 1/20 0.41
DHFR P00374 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.40
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10623359 0.90 TSPO (0.46) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL9809626 0.85 MEN1 (0.48) NR1H2NR1H3TSHRALDH1A1SMN1; SMN2
SCHEMBL6982805 0.82 NR1H2 (0.58) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL2881081 0.80 CYP2C19 (0.52) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL7789996 0.80 CHRNB2 (0.57) ALDH1A1KDM4E
SCHEMBL11881187 0.79 NR1H2 (0.62) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL642317 0.79 CRHBP (0.61) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL5604665 0.78 TSPO (0.57) NR1H2NR1H3TSHRALDH1A1AOC3
SCHEMBL10786006 0.78 CRHBP (0.57) NR1H2NR1H3TSHRALDH1A1CRHBP
SCHEMBL12772106 0.78 MEN1 (0.55) NR1H2NR1H3ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414216-B1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2020-10-21 EP claimed
US-20190040028-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2019-02-07 US claimed
EP-3414216-A1 ARYLATION OF ALIPHATIC AMINES AAA Chemistry ApS (DK) 2018-12-19 EP claimed
WO-2017137047-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2017-08-17 WO claimed
EP-3414216-B1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2020-10-21 EP disclosed
EP-3414216-B1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2020-10-21 EP disclosed
US-20190040028-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2019-02-07 US disclosed
US-20190040028-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2019-02-07 US disclosed
EP-3414216-A1 ARYLATION OF ALIPHATIC AMINES AAA Chemistry ApS (DK) 2018-12-19 EP disclosed
WO-2017137047-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2017-08-17 WO disclosed
WO-2017137047-A1 ARYLATION OF ALIPHATIC AMINES AAA CHEMISTRY APS (DK) 2017-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190040028-A1 ARYLATION OF ALIPHATIC AMINES NAT1, AHR, ABL1 NR1H2 2404/4885NR1H3 1942/4885TSHR 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.